(Q33979590)

30 July 2017

1 reference

title

C-peptide: new findings and therapeutic implications in diabetes (English)

1 reference

30 July 2017

1

John Wahren

1 reference

30 July 2017

1 July 2004

1 reference

Clinical Physiology and Functional Imaging

30 July 2017

1 reference

30 July 2017

24

1 reference

30 July 2017

4

1 reference

30 July 2017

180-189

1 reference

Diabetic neuropathy, nerve growth factor and other neurotrophic factors

30 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Effects of C-peptide on forearm blood flow and brachial artery dilatation in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Reversal of lesions of diabetic nephropathy after pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Molecular basis for the insulinomimetic effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Activation of orphan receptors by the hormone relaxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide improves adenosine-induced myocardial vasodilation in type 1 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

The changing natural history of nephropathy in type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Pancreas transplantation and diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Proinsulin C peptide obviates sympathetically mediated suppression of splenic lymphocyte activity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide binding to human cell membranes: importance of Glu27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Specific binding of proinsulin C-peptide to human cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Effects of C-peptide on glomerular and renal size and renal function in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1475-097X.2004.00558.X

10.1111/J.1475-097X.2004.00558.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

15233831